Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Another ReNu Recall Begins While 2006 Episode Clouds B&L Earnings

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb announced a voluntary recall of its ReNu MultiPlus contact lens solution the same day it reported the May 2006 worldwide recall of ReNu with MoistureLoc "led to declines in consolidated gross margins" for the full year

You may also be interested in...



Contact Lens Care Solutions Should Require “Rubbing” – FDA Panel

All multipurpose contact lens care solutions should include directions for "rubbing" as well as rinsing to help avoid potential eye infections, including solutions previously approved with "no rub" labels on exterior packaging, FDA's Ophthalmic Devices Panel says

Contact Lens Care Solutions Should Require “Rubbing” – FDA Panel

All multipurpose contact lens care solutions should include directions for "rubbing" as well as rinsing to help avoid potential eye infections, including solutions previously approved with "no rub" labels on exterior packaging, FDA's Ophthalmic Devices Panel says

Contact Lens Care Solutions Should Require “Rubbing” – FDA Panel

All multipurpose contact lens care solutions should include directions for "rubbing" as well as rinsing to help avoid potential eye infections, including solutions previously approved with "no rub" labels on exterior packaging, FDA's Ophthalmic Devices Panel says

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel